By Josh White
Date: Friday 07 Nov 2025
(Sharecast News) - Tissue Regenix warned on Friday that it urgently needs to raise fresh capital to remain in business, after uncovering a significant creditor backlog and limited cash reserves.
By Josh White
Date: Friday 17 Oct 2025
(Sharecast News) - Tissue Regenix announced on Friday that its chief financial officer Kirsten Lund had joined the company's board with immediate effect.
By Josh White
Date: Monday 09 Jun 2025
(Sharecast News) - Tissue Regenix announced on Monday that it has received CE and UKCA certifications for its OrthoPure XT biological tendon replacement device, securing continued access to key European and UK medical device markets.
| Currency | UK Pounds |
| Share Price | 7.25p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 7.25p |
| 52 Week Low | 7.25p |
| Volume | 0 |
| Shares Issued | 71.40m |
| Market Cap | £5.18m |
| RiskGrade | 22 |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
You are here: research